• In the media
  • Big pharma' urged to develop treatments for g...
Media - published on 20 Nov 2018

Big pharma' urged to develop treatments for global health

Anne Gulland reports on how the 2018 Index found that just five firms — GSK, Johnson & Johnson, Sanofi, Merck and Novartis — are conducting two thirds of the research and development into diseases that urgently need treatments.

She notes: "GSK topped the overall list of pharmaceutical companies in terms of providing access, followed by Novartis, Johnson & Johnson and Merck. Bottom of the list of 20 global companies was the US firm Eli Lilly."

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.